Mansukani Sharad 4
4 · agilon health, inc. · Filed Sep 15, 2021
Insider Transaction Report
Form 4
Mansukani Sharad
Director
Transactions
- Exercise/Conversion
Common Stock
2021-09-14$1.00/sh+156,250$156,250→ 1,385,606 total - Sale
Common Stock
2021-09-14$28.98/sh−156,250$4,528,125→ 1,229,356 total - Exercise/Conversion
Options (Rights to Buy)
2021-09-14−156,250→ 493,750 totalExercise: $1.00Exp: 2027-04-27→ Common Stock (156,250 underlying)
Footnotes (2)
- [F1]Includes restricted stock units.
- [F2]These options were granted on April 27, 2017, and fully vested on July 1, 2020.